Mirion Technologies MIR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $72.1M+5.1% | $82.5M-3.6% | $78.5M+5.9% | $81.2M+10.9% | $68.6M+2.7% | |
| Nuclear & Safety | $185.5M+39.1% | $194.9M+15.5% | $144.6M+9.0% | $141.7M+5.8% | $133.4M+6.0% | |
| Segment Income From Operations by Business | ||||||
| Medical Segment | $7.8M+16.4% | $18.6M+56.3% | $10.7M+168% | $10.9M+118% | $6.7M+379% | |
| Nuclear & Safety | $20.9M-3.7% | $39.1M+18.1% | $21.3M+44.9% | $19M+2.7% | $21.7M+72.2% | |
| Adjusted Income Loss From Operations by Business | ||||||
| Medical Segment | -$25.4M-3.7% | -$27.1M+10.0% | -$27.8M-3.3% | -$29.6M-13.0% | -$24.5M+3.9% | |
| Nuclear & Safety | -$99.5M-43.8% | -$100M-11.7% | -$77M-6.6% | -$77.8M-9.9% | -$69.2M-1.9% | |
| Other segment items by Business | ||||||
| Medical Segment | $38.9M+4.0% | $36.8M-15.6% | $40M-7.4% | $40.7M-3.1% | $37.4M-6.3% | |
| Nuclear & Safety | $65.1M+53.2% | $55.8M+21.0% | $46.3M+1.1% | $44.9M+0.7% | $42.5M-6.2% | |
| D&A by Business | ||||||
| Medical Segment | $16.2M-1.2% | $16.2M-6.4% | $16.6M-10.8% | $16.3M-12.4% | $16.4M-11.4% | |
| Nuclear & Safety | $24.3M+42.9% | $19.3M+13.5% | $18.1M-8.6% | $17.3M-12.6% | $17M-15.4% | |
| CapEx by Business | ||||||
| Medical Segment | $3.7M-21.3% | $6.2M+12.7% | $5.5M-22.5% | $3.8M-44.1% | $4.7M-45.3% | |
| Nuclear & Safety | $4.8M+37.1% | $5.4M-16.9% | $5M+38.9% | $4.8M+23.1% | $3.5M-5.4% | |
| Translation adjustment by Business | ||||||
| Medical Segment | $0— | $0— | $0— | $0— | $0— | |
| Nuclear & Safety | -$9.6M-172% | $2M+136% | $300K+105% | $31.1M+665% | $13.4M+344% | |
| Goodwill by Business | ||||||
| Medical Segment | $634M0.0% | $634M0.0% | $634M— | $634M— | $634M— | |
| Nuclear & Safety | $1.23B+52.2% | $1.24B+56.3% | $55.7M— | $836.7M— | $805.6M— | |
| Measurement period adjustment by Business | ||||||
| Medical Segment | $0— | —— | —— | —— | —— | |
| Nuclear & Safety | -$2.4M— | —— | —— | —— | —— | |
| Total revenues by Product | ||||||
| Cancer care | $55.3M+8.4% | $63.9M-3.2% | $62M+8.6% | $62.2M+11.1% | $51M+4.3% | |
| Labs and research | $28.3M+5.6% | $34M-7.1% | $34M-4.0% | $27.4M+2.6% | $26.8M-18.8% | |
| Nuclear power | $125.8M+49.6% | —— | —— | —— | $84.1M— | |
| Other | $16.8M-4.5% | $34.4M+0.3% | $28.8M+10.8% | $32.2M+3.2% | $17.6M-17.4% | |
| Total cost of revenues by Product | ||||||
| Product | $112.9M+38.2% | $112.7M+10.8% | $89.5M+4.3% | $92.7M+12.8% | $81.7M+3.4% | |
| Service | $25.6M+5.8% | $29.2M-3.6% | $29.1M+3.6% | $27.7M+0.7% | $24.2M-8.7% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $4.7M-19.0% | $4.4M+46.7% | $3.2M+10.3% | $2.2M+83.3% | $5.8M0.0% | |
| Europe | $77.9M+18.9% | $104.7M+9.6% | $75.7M+15.9% | $81.8M+6.1% | $65.5M-3.4% | |
| North America | $175M+33.9% | $168.3M+8.0% | $144.2M+4.0% | $138.9M+7.8% | $130.7M+9.8% | |
| Property, plant, and equipment, net by Geography | ||||||
| Asia Pacific | $100K0.0% | $100K0.0% | $100K— | $100K— | $100K— | |
| Europe | $58.6M+4.1% | $61.4M+12.2% | $61M— | $60.9M— | $56.3M— | |
| North America | $93.9M+2.3% | $93.4M+2.1% | $92.2M— | $92.1M— | $91.8M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.